|
Clusterin may be biomarker for asthma severity
Healio Clusterin may be a biomarker of asthma severity and the burden of oxidative stress in patients with asthma, and the expression may be a useful way to assess airway inflammation, according to data from a recent study. “Oxidative stress is important in … |
View full post on asthma – Google News